Renee Susko
Family Medicine · Detroit, MINPI 1376585810
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $348 and has fallen 95.4% since, to $16 in 2025.
Across 68 payments — averaging $23.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$358
- Radius Health, Inc.$176
- Teva Pharmaceuticals USA, Inc.$147
- Amgen$136
- Novo Nordisk$122
- Novartis$109
- plus $534 from 16 others
What the payments were for
- Food & beverage$1,48794%
- Education$956%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 8 | $358 |
| Radius Health, Inc. | 3 | $176 |
| Teva Pharmaceuticals USA, Inc. | 8 | $147 |
| Amgen | 7 | $136 |
| Novo Nordisk | 8 | $122 |
| Novartis | 6 | $109 |
| Astellas Pharma US Inc | 2 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $56 |
| Lilly USA, LLC | 3 | $48 |
| Lundbeck LLC | 2 | $39 |
| Fidia Pharma USA Inc. | 1 | $34 |
| Pfizer | 2 | $33 |
| Johnson & Johnson | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $26 |
| Alkermes, Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Seqirus USA Inc | 1 | $16 |
| AstraZeneca | 1 | $16 |
| GSK | 1 | $15 |
| Alvogen Inc | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,582 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $751 |
| Levothyroxine Sodium | 42 | $511 |
| Pravastatin Sodium | 17 | $180 |
| Metformin Hcl | 11 | $150 |
| Allopurinol | 12 | $131 |
| Atorvastatin Calcium | 14 | $115 |
| Spironolactone | 13 | $86 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 11 | $72 |
| Sertraline Hcl | 16 | $66 |
| Lisinopril | 19 | $56 |
| Potassium Chloride | 14 | $44 |
| Ropinirole Hcl | 14 | $27 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Detroit
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
- James VoigtOak Park$140K
- Timothy IzzoGrand Ledge$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.